First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study

Zev A. Wainberg, Tanios Bekaii-Saab, Patrick M. Boland, Farshid Dayyani, Teresa Macarulla, Kabir Mody, Bruce Belanger, Fiona Maxwell, Yan Moore, Arunthathi Thiagalingam, Tiffany Wang, Bin Zhang, Andrew Dean

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'First-line liposomal irinotecan with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) in pancreatic ductal adenocarcinoma: A phase I/II study'. Together they form a unique fingerprint.

Medicine & Life Sciences